↓ Skip to main content

Dove Medical Press

GABAergic system in the endocrine pancreas: a new target for diabetes treatment

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, February 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

news
2 news outlets
twitter
4 X users
facebook
1 Facebook page
wikipedia
1 Wikipedia page
googleplus
1 Google+ user

Citations

dimensions_citation
79 Dimensions

Readers on

mendeley
120 Mendeley
Title
GABAergic system in the endocrine pancreas: a new target for diabetes treatment
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, February 2015
DOI 10.2147/dmso.s50642
Pubmed ID
Authors

Yun Wan, Qinghua Wang, Gerald J Prud’homme

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 120 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Austria 2 2%
Italy 1 <1%
Unknown 117 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 18%
Student > Ph. D. Student 17 14%
Student > Master 17 14%
Student > Bachelor 12 10%
Student > Doctoral Student 5 4%
Other 16 13%
Unknown 31 26%
Readers by discipline Count As %
Agricultural and Biological Sciences 23 19%
Biochemistry, Genetics and Molecular Biology 17 14%
Medicine and Dentistry 14 12%
Neuroscience 6 5%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Other 19 16%
Unknown 36 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2023.
All research outputs
#1,880,145
of 25,457,858 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#84
of 1,184 outputs
Outputs of similar age
#25,689
of 361,566 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#3
of 9 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,184 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,566 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 6 of them.